← brief for 2026-08-29 · People & money

Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up

Paper B Peer reviewed Small trial

Key takeaways

This study compared two drugs for overactive parathyroid glands in 1,240 people on dialysis over two years. The newer drug (etelcalcetide) lowered calcium and phosphorus slightly better than cinacalcet, but both had similar side effects like low calcium levels.

Who did this work

Hakkı Öztürk (Afyon Kocatepe University) · Çiğdem Ikhlef (Memorial Ankara Hospital) · Berrak Itır Aylı (University of Westminster) · Vivek Tomar (Gazi University) · Bartu Ediz (Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi) · Ebru Gok Oguz (Memorial Ankara Hospital) · Elif Arı Bakır (Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi) · Galip Güz (Gazi University) · Mehmet Deniz Aylı (Memorial Ankara Hospital)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-08-28
https://doi.org/10.3390/jcm15176656